Yale Catriona's Form 4 filing
Akero Therapeutics, Inc. (AKRO) · filed Jun 20, 2025
- Accession no.
- 0000950170-25-088207
- Filed
- Jun 20, 2025
- Trade date
- Jun 16, 2025
- Filing delay
- 4 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $542.3K. It was filed 4 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yale CatrionaCIK 0001779308 | Officer (Chief Development Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | Common Stock | MOption exerciseAcquired | +10,000 | $21.10 | +$211,000 | 102,231 | Direct | |
| Jun 16, 2025 | Common Stock | SSaleDisposed | −6,210 | $53.78 | −$333,973.8 | 96,021 | Direct | |
| Jun 16, 2025 | Common Stock | SSaleDisposed | −2,895 | $54.80 | −$158,646 | 93,126 | Direct | |
| Jun 16, 2025 | Common Stock | SSaleDisposed | −895 | $55.52 | −$49,690.4 | 92,231 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | Common Stock | MOption exerciseDisposed | −29,073 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.